Country sequencing, vendor geography, and QP release chains are strategic decisions made, well or poorly, at the US IND stage, long before a company believes it is ready to think globally.
White Paper
Designing a Global IND Strategy Before You Think You Need One
Related Resources
All Resources
infographic
Navigating the Regulatory Crossroads of Drug, Device, and Biologic
Read More
post
FDA PreCheck Program vs. Fast Track: Facility Readiness
Read More
post
QSR Is Gone. What Combination Product Sponsors Need to Know About the QMSR Switchover.
Read More
post
Another Nitrosamine Recall. Another Reminder That This Problem Isn’t Going Away.
Read More
Let's move from science to success.
Let’s Talk